• Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
    • Voir la rubrique recherche
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
    • Voir la rubrique sélections
    • Présentation
    • Contact
    • Voir la rubrique À propos

Entrez vos termes ici. Par défaut, la recherche utilise OU. Ajoutez « + » entre les termes pour une recherche avec ET. Pour plus d'options, consultez la Recherche avancée.

  • Aide
  • Recherche avancée
  • Périodiques

Recherche utilisant l'IA (non conversationnelle - chaque question est indépendante)

  • Aide

Portail documentaire

Site OFDT
Historique
Se connecter
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
    • Voir la rubrique recherche
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
    • Voir la rubrique sélections
    • Présentation
    • Contact
    • Voir la rubrique À propos
Sélectionner un type de recherche

Entrez vos termes ici. Par défaut, la recherche utilise OU. Ajoutez « + » entre les termes pour une recherche avec ET. Pour plus d'options, consultez la Recherche avancée.

  • Aide
  • Recherche avancée
  • Périodiques

Recherche utilisant l'IA (non conversationnelle - chaque question est indépendante)

  • Aide
  1. Accueil
  2. Retour

Éditeur Europol

localisé à :
The Hague

22 Documents disponibles chez cet éditeur

  Ajouter le résultat à votre sélection
  Affiner la recherche
Amphetamine-type stimulants in the European Union 1998-2007. Europol contribution to the Expert Consultations for the UNGASS assessment

Amphetamine-type stimulants in the European Union 1998-2007. Europol contribution to the Expert Consultations for the UNGASS assessment

Europol | 2007
Rapport
Drug matters appear high on the political agenda of the European Union. In the last decade, two successive European Union Drug Strategies and their related Action Plans were endorsed and implemented. In the area of synthetic drugs, a specific Ac[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Complexities and conveniences in the international drug trade: The involvement of Mexican criminal actors in the EU drug market

Complexities and conveniences in the international drug trade: The involvement of Mexican criminal actors in the EU drug market

Europol ; Drug Enforcement Administration | 2022
Rapport
This report delves into the activities of these criminals and their methods. Drug trafficking operations benefit from a number of different actors, such as brokers, cooks, envoys, intermediaries, and money laundering service providers. Examples [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Drugs and the darknet: perspectives for enforcement, research and policy

Drugs and the darknet: perspectives for enforcement, research and policy

OEDT = EMCDDA ; Europol | 2017
Rapport
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they r[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Documents numériques
EMCDDA-Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA)

EMCDDA-Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide, commonly known as CUMYL-4CN-BINACA, through a joint assessment. The two or[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl)

EMCDDA-Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2018
Rapport
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), through a joint assessment. The two organisat[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil)

EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB)

EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint asses[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA)

EMCDDA-Europol Joint Report on a new psychoactive substance: methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2016
Rapport
In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment.[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as ADB-CHMINACA, through a joint [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide, commonly known as AB-CHMINACA, through a joint asses[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In September 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, commonly known as acryloylfentanyl, through a joint assessment. The two organisations [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide, commonly known as 4-fluoroisobutyrylfentanyl (4F-iBF), through a joint ass[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2018
Rapport
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), through a joint assessment. The two organis[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EMCDDA-Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F)

EMCDDA-Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances

OEDT = EMCDDA ; Europol | 2017
Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide, commonly known as tetrahydrofuranylfentanyl (THF-F), through a [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Document numérique
EU Drug markets analysis: Key insights for policy and practice

EU Drug markets analysis: Key insights for policy and practice

OEDT = EMCDDA ; Europol | 2024
Rapport
This resource offers a strategic and top-level summary for policymakers and decision-makers, to support the development and implementation of policies and actions in Europe, based on a robust understanding of the current drug landscape and emerg[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Document numeriques Documents numériques

  1. première page
  2. page précédente
  3. 1
  4. 2
  5. page suivante
  6. dernière page

(1 - 15 / 22)

Par page :

  • 25
  • 50
  • 100
  • 200

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site